Irinotecan in Treating Patients With Recurrent Glioma

Clinical trial NCT00003134 · COMPLETED

Trial details

NCT number: NCT00003134
Sponsor: Alliance for Clinical Trials in Oncology
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors

Start date: 1998-01-01
Primary completion: 2001-10-01
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.